CONTENTS:
- Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion? [Editorial]. Hughes B., Vandam L., Mounteney J., Griffiths P., p. 3-4.
- The effectiveness and tolerability of anti-seizure medication in alcohol withdrawal syndrome: a systematic review, meta-analysis and GRADE of the evidence. Lai J.Y., Kalk N., Roberts E., p. 5-18.
- Reward-related decision-making deficits in internet gaming disorder: a systematic review and meta-analysis. Yao Y.W., Zhang J.T., Fang X.Y., Liu L., Potenza M.N., p. 19-32.
- Causal mechanisms proposed for the alcohol harm paradox - A systematic review. Boyd J., Sexton O., Angus C., Meier P., Purshouse R.C., Holmes J., p. 33-56.
- Trajectories of alcohol misuse among the UK Armed Forces over a 12-year period. Palmer L., Norton S., Jones M., Rona R.J., Goodwin L., Fear N.T., p. 57-67.
- Overestimation of alcohol consumption norms as a driver of alcohol consumption: a whole-population network study of men across eight villages in rural, southwestern Uganda. Perkins J.M., Kakuhikire B., Baguma C., Jurinsky J., Rasmussen J.D., Satinsky E.N., et al., p. 68-81.
- Predictors of early and sustained cessation of heavy drinking over 5 years among adult primary care patients. Palzes V.A., Kline-Simon A.H., Satre D.D., Sterling S., Weisner C., Chi F.W., p. 82-95.
- Alcohol use disorder and non-fatal suicide attempt: findings from a Swedish National Cohort Study. Edwards A.C., Ohlsson H., Moscicki E., Crump C., Sundquist J., Kendler K.S., et al., p. 96-105.
- Commentary on Edwards et al.: Alcohol use disorder-a different impact in young adulthood than later? Falkstedt D., p. 106-107.
- Effects of a minimal-guided on-line intervention for alcohol misuse in Estonia: a randomized controlled trial. Augsburger M., Kaal E., Ülesoo T., Wenger A., Blankers M., Haug S., et al., p. 108-117.
- Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study. Knuijver T., Schellekens A., Belgers M., Donders R., van Oosteren T., Kramers K., et al., p. 118-128.
- Prevalence of co-occurring mental illness and substance use disorder and association with overdose: a linked data cohort study among residents of British Columbia, Canada. Keen C., Kinner S.A., Young J.T., Jang K., Gan W., Samji H., et al., p. 129-140.
- The association of Medicare Part D prior authorization for buprenorphine-naloxone with adherence to opioid use disorder treatment guidelines in the United States. Parish W.J., Mark T.L., Zarkin G.A., Weber E., p. 141-150.
- Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial. Hser Y.I., Zhu Y., Fei Z., Mooney L.J., Evans E.A., Kelleghan A., et al., p. 151-161.
- Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments. Faherty L.J., Heins S., Kranz A.M., Patrick S.W., Stein B.D., p. 162-171.
- Quantification of prenatal marijuana use: evaluation of the correlation between self-report, serum, urine and umbilical cord assays among women delivering at two urban Colorado hospitals. Metz T.D., McMillin G.A., Silver R.M., Allshouse A.A., Heard K., Jensen T.L., et al., p. 172-181.
- Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016-20. Price O., Man N., Bruno R., Dietze P., Salom C., Lenton S., et al., p. 182-194.
- New means, new measures: assessing prescription drug-seeking indicators over 10 years of the opioid epidemic. Perry B.L., Odabas M., Yang K.C., Lee B., Kaminski P., Aronson B., et al., p. 195-204.
- Commentary on Perry et al.: New means, new measures - without discarding all the previous ones! Soeiro T., Micallef J., p. 205-206.
- Changes in dependence, withdrawal, and craving among adult smokers who switch to nicotine salt pod-based e-cigarettes. Leavens E.L.S., Nollen N.L., Ahluwalia J.S., Mayo M.S., Rice M., Brett E.I., et al., p. 207-215.
- Rising vape pod popularity disrupted declining use of electronic nicotine delivery systems among young adults in Texas, USA from 2014 to 2019. Loukas A., Marti C.N., Pasch K.E., Harrell M.B., Wilkinson A.V., Perry C.L., p. 216-223.
- E-cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: randomized controlled trial. Myers Smith K., Phillips-Waller A., Pesola F., McRobbie H., Przulj D., Orzol M., et al., p. 224-233.
- Association of selective serotonin re-uptake inhibitor (SSRI) treatment with acute substance misuse outcomes. Virtanen S., Lagerberg T., Khemiri L., Suvisaari J., Larsson H., Lichtenstein P., et al., p. 234-242.
- A wastewater-based assessment of the impact of a minimum unit price (MUP) on population alcohol consumption in the Northern Territory, Australia. O'Brien J.W., Tscharke B.J., Bade R., Chan G., Gerber C., Mueller J.F., et al., p. 243-249.
- Prenatal methamphetamine-impact on the mother and child-a review. Perez F.A., Blythe S., Wouldes T., McNamara K., Black K.I., Oei J.L., p. 250-260.